Gliclazide Mr Stada

Gliclazide MR Stada is a modified-release oral medication used to manage type 2 diabetes. It helps control blood sugar levels by stimulating insulin release from the pancreas.

Gliclazide MR Stada is primarily used to treat type 2 diabetes. It works by helping the pancreas produce more insulin, which helps lower blood sugar levels. This medication is often prescribed for individuals who have not achieved adequate blood sugar control through diet and exercise alone. Gliclazide MR Stada is designed for oral use and is taken once daily.

Common effects of Gliclazide MR Stada may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and confusion. Other possible effects include nausea, vomiting, and stomach pain. It is important to monitor blood sugar levels regularly while taking this medication.

Gliclazide MR Stada should be handled with care, especially by individuals with a history of liver or kidney disease. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children.

Gliclazide MR Stada may interact with other medications, including certain antibiotics, antifungal drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be avoided while taking this medication, as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.